Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)
NCT ID: NCT01321307
Last Updated: 2011-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Breezy Candy on Halitosis
NCT00875927
Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
NCT00250289
Day Long Prevention of Oral Malodor With a Palatal Patch (SmellX) Containing A Herbal Formula
NCT01388023
Hydrogen Sulfide Production by Oral Microflora
NCT00396539
Clinical Evaluation of MucoPEG™ for Xerostomia
NCT04986501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sorend
Group no. 1 shall receive Sorend following diagnosis of aphtostomatitis or mucositis.
No interventions assigned to this group
Sorend placebo
Group no. 2 shall receive Sorend placebo following diagnosis of aphtostomatitis or mucositis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bacterial aphtostomatitis
* Viral aphtostomatitis
* Fungal aphtostomatitis
Exclusion Criteria
* Systematic diseases (Colitis, Crohn, diabetes, Behcet)
* Pregnancy
* Arthritis
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
R&T Health Products Ltd.
INDUSTRY
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hillel Yaffe Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galit Avior, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center, Hadera, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe MC, Otolaryngology - Head & Neck Surgery Unit
Hadera, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Galit Avior, MD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
91-2010-HYMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.